<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: We compared the expression of genes related to inflammatory and cytotoxic functions between MSI and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e> (HLA-class I-negative and HLA-class I-positive) <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>), seeking evidence of differences in <z:mp ids='MP_0002501'>inflammatory mediators</z:mp> and cytotoxic T-cell responses </plain></SENT>
<SENT sid="1" pm="."><plain>Twenty-two <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> were divided into three study groups as a function of HLA class I expression and MSI phenotype: 8 MSI <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>, 6 MSS/HLA- <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> and 6 MSS/HLA+ <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> (controls) </plain></SENT>
<SENT sid="2" pm="."><plain>FINDINGS: A first comparison between eight MSI and six <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e>/HLA-positive (control) <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, based on microarray analysis on an Affymetrix(®) HG-U133-Plus-PM plate, identified 1974 differentially expressed genes (P &lt; 0.05) </plain></SENT>
<SENT sid="3" pm="."><plain>We grouped genes in Gene Ontology functional categories: apoptotic programme (72 genes, P = 5.5·10(-3)), leucocyte activation (43 genes, P = 1.8·10(-5)), T-cell activation (24 genes, P = 6.3·10(-4)), <z:mp ids='MP_0001845'>inflammatory response</z:mp> (40 genes, 2.3·10(-2)) and cytokine production (10 genes, P = 1.9·10(-2)) </plain></SENT>
<SENT sid="4" pm="."><plain>Real-time PCR and immunohistochemical evaluation were used to validate the data, finding that increased <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels of pro-inflammatory cytokines and cytotoxic mediators were associated with greater infiltration by CD8+T lymphocytes in the MSI group (P &lt; 0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>Finally, HLA-class I-negative <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> were not grouped together but rather in accordance with features of the gene expression profile of MSI or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>As expected, genes associated with antigen processing machinery and MHC class I molecules (TAP2, B2m) were downregulated in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e>/HLA-class I-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> (n = 6) in comparison to controls </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: In conclusion, microarray and immunohistochemical data may be useful to comprehensively assess <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-host interactions and differentiate MSI from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>The two types of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>, MSI/HLA-class I-negative and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e>/HLA-class I-negative, showed marked differences in the composition and intensity of infiltrating leucocytes, suggesting that their immune escape strategies involve distinct pathways </plain></SENT>
</text></document>